TransCode Share Price
NASDAQ: RNAZ | Micro Cap | HealthcareTransCode Stock Performance
TransCode Share Price Today
As of 22 November 2026, TransCode Therapeutics, Inc.'s share price is $1.14. The stock opened at $1.16, compared to its previous close of $1.28. During today's trading session, TransCode Therapeutics, Inc.'s share price traded between $1.13 and $1.16, with an average price of $1.14. Over the past 52 weeks, the stock has recorded a high of $11.97 and a low of $1.13. In terms of performance, TransCode Therapeutics, Inc.'s share price has declined by 78.77% over the last six months and is down 87.41% on a year-on-year basis.
TransCode Share Price Chart
TransCode Quarterly Profit & Loss
All figures in USD
TransCode Annual Profit & Loss
All figures in USD
TransCode Balance Sheet
All figures in USD Million
TransCode Cash Flow
All figures in USD Million
Corporate Actions
About TransCode
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
TransCode Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.65 | $1.14 | -34.86% |
Oct 2026 | $1.59 | $1.75 | +5.42% |
Sep 2026 | $2.10 | $1.66 | -41.45% |
Aug 2026 | $4.09 | $2.83 | -46.00% |
Jul 2026 | $6.56 | $5.25 | +3.35% |
Jun 2026 | $4.01 | $5.08 | -5.40% |
May 2026 | $7.58 | $5.37 | -37.27% |
Apr 2026 | $7.88 | $8.56 | +0.12% |
Mar 2026 | $9.65 | $8.55 | -13.94% |
Feb 2026 | $11.73 | $9.94 | -5.47% |
Jan 2026 | $7.16 | $10.51 | +58.16% |
Dec 2025 | $9.75 | $6.64 | -26.62% |